AstraZeneca’s Imfinzi is adding yet another landmark perioperative label to its belt with a new FDA approval that gives the ...
MedPage Today on MSN
FDA OKs Perioperative Immunotherapy for Stomach Cancer
The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable ...
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric ...
Imfinzi is the first immunotherapy approved for perioperative use to treat gastric and gastroesophageal junction cancers.
Stomach cancer is difficult to detect early because its symptoms often resemble common digestive issues. Experts warn that ...
My 39-year-old brother was just diagnosed with gastric cancer. The diagnosis was especially shocking because of his age. Is ...
Smoking is one of the biggest preventable causes of stomach cancer. Oncologist explains how tobacco damages the stomach ...
Stomach Cancer is known to be an illness most frequently seen in elderly people over 50 to 70 years of age. However, these ...
Diet is among the most likely contributors to the increase in early-onset stomach cancer. Over the past decades, the typical ...
Early-stage gastric cancer can be assessed more accurately using a new liquid biopsy tool that predicts lymph node metastasis ...
Stomach cancer is a malignant tumor that begins in the stomach lining, often caused by abnormal cell growth due to DNA ...
Tuko News on MSN
Kitengela Man Pleads for Help to Raise KSh 6.9m and Help Daughter with Kidney Cancer
A man identified as Vincent Mutua was shocked and saddened when he learnt that his son was suffering from kidney cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results